Influence of serum collected from rat perfused with compound Biejiaruangan drug on hepatic stellate cells.
暂无分享,去创建一个
M. Dai | Wei Zhang | Yixiao Meng | Li-yun Zhao | T. Jiang | J. Niu | Shun-Gen Guo | Luxi Zhang
[1] K. Kharbanda,et al. Inhibition of markers of hepatic stellate cell activation by the hormone relaxin. , 2003, Biochemical pharmacology.
[2] S. Brenner,et al. Duplication, degeneration and subfunctionalization of the nested synapsin-Timp genes in Fugu. , 2003, Trends in genetics : TIG.
[3] Wen-bin Liu,et al. Inhibition on the production of collagen type I, III of activated hepatic stellate cells by antisense TIMP-1 recombinant plasmid. , 2003, World journal of gastroenterology.
[4] R. Hultcrantz,et al. The Myofibroblastic Conversion of Peribiliary Fibrogenic Cells Distinct from Hepatic Stellate Cells Is Stimulated by Platelet-Derived Growth Factor During Liver Fibrogenesis , 2003, Laboratory Investigation.
[5] R. Kalluri,et al. Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. , 2003, Gastroenterology.
[6] H. Yoshiji,et al. Tissue inhibitor of metalloproteinases‐1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse , 2002, Hepatology.
[7] Nong Zhang,et al. Effect of retinoid kappa receptor alpha (RXRalpha) transfection on the proliferation and phenotype of rat hepatic stellate cells in vitro. , 2002, Chinese medical journal.
[8] A. Gressner,et al. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[9] G. Marinos,et al. Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection. , 2002, Liver.
[10] J. Nan,et al. Aloe emodin suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. , 2002, Pharmacology & toxicology.
[11] John P. Iredale,et al. Inhibition of Apoptosis of Activated Hepatic Stellate Cells by Tissue Inhibitor of Metalloproteinase-1 Is Mediated via Effects on Matrix Metalloproteinase Inhibition , 2002, The Journal of Biological Chemistry.
[12] Ping Wang,et al. [Expression and significance of platelet derived growth factor and its receptor in liver tissues of patients with liver fibrosis]. , 2002, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.
[13] D. Bissell. Chronic liver injury, TGF-β, and cancer , 2001, Experimental & Molecular Medicine.
[14] R. Hernández-Muñoz,et al. Adenosine reverses a preestablished CCl4‐induced micronodular cirrhosis through enhancing collagenolytic activity and stimulating hepatocyte cell proliferation in rats , 2001, Hepatology.
[15] J. Iredale. Hepatic Stellate Cell Behavior during Resolution of Liver Injury , 2001, Seminars in liver disease.
[16] S. Kojima,et al. Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta. , 2001, Gastroenterology.
[17] K. Okita,et al. Characteristics of the cell proliferation profile of activated rat hepatic stellate cells in vitro in contrast to their fibrogenesis activity , 2001, Journal of Gastroenterology.
[18] M. Manns,et al. Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C. , 2001, Journal of hepatology.
[19] P. Greengard,et al. Identification of synapsin I peptides that insert into lipid membranes. , 2001, The Biochemical journal.
[20] Manoel Luis Costa,et al. Intermediate filaments modulation in an in vitro model of the hepatic stellate cell activation or conversion into the lipocyte phenotype. , 2001, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[21] D. Bissell. Chronic liver injury, TGF-beta, and cancer. , 2001, Experimental & molecular medicine.
[22] S. Thorgeirsson,et al. Tissue inhibitor of metalloproteinases‐1 promotes liver fibrosis development in a transgenic mouse model , 2000, Hepatology.
[23] N. Shiojiri,et al. Immunohistochemical analysis of development of desmin‐positive hepatic stellate cells in mouse liver , 2000, Journal of anatomy.
[24] X. Liu,et al. [Inhibition of the activation and collagen production of cultured rat hepatic stellate cells by antisense oligonucleotides against transforming growth factor-beta 1 is enhanced by cationic liposome delivery]. , 2000, Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao.
[25] J. Zhang,et al. Expression of fibronectin receptor, integrin alpha 5 beta 1 of hepatic stellate cells in rat liver fibrosis. , 2000, Chinese medical journal.
[26] R. Gebhardt,et al. Common myofibroblastic features of newborn rat astrocytes and cirrhotic rat liver stellate cells in early cultures and in vivo , 1999, Neurochemistry International.
[27] Q. Zhang,et al. [Effects of interferon-alpha on the mRNA expression of procollagen type I and III of hepatic stellate cells and on the deposition of collagen type I and III in fibrotic liver of rats]. , 1999, Zhonghua yi xue za zhi.
[28] A. Burt. Pathobiology of hepatic stellate cells , 1999, Journal of Gastroenterology.
[29] H. Tsukamoto,et al. Cytokine regulation of hepatic stellate cells in liver fibrosis. , 1999, Alcoholism, clinical and experimental research.
[30] A. Desmoulière,et al. Effect of pentoxifylline on early proliferation and phenotypic modulation of fibrogenic cells in two rat models of liver fibrosis and on cultured hepatic stellate cells. , 1999, Journal of hepatology.
[31] C. Liu,et al. Effects of Fuzhenghuayu decoction on collagen synthesis of cultured hepatic stellate cells, hepatocytes and fibroblasts in rats. , 1998, World journal of gastroenterology.
[32] P. Calès. Apoptosis and liver fibrosis: antifibrotic strategies. , 1998, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.